Tandem bispecific CD123/CLL‐1 CAR‐T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia

XY Wang, MR Bian, GQ Lin, L Yu… - European Journal of …, 2024 - Wiley Online Library
Objectives The treatment of refractory and recurrent acute myeloid leukaemia (AML) is still a
challenge with poor response rates and short survival times. In an attempt to solve this …

External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study

A Franco-Moreno, JB Morejón-Girón… - Clinical and …, 2024 - Springer
Introduction Venous thromboembolism (VTE) may be the first sign of an undiagnosed
cancer. The RIETE and SOME scores aim to identify patients with acute VTE at high risk of …

[HTML][HTML] Unprovoked venous thromboembolism recurrence and arterial embolism revealing lung cancer: a case report

MC Glodeanu, V Mutruc… - Thrombosis …, 2024 - thrombosisjournal.biomedcentral …
The link between venous thromboembolism (VTE) and cancer is well known. VTE could be
the initial sign of an occult malignancy. There are more diagnoses of cancer after an …

The Benefit of an Extensive Cancer Screening Strategy After the First Episode of Unprovoked Pulmonary Embolism

A Bouchlarhem, I Lahmidi, Z Bazid… - Critical Pathways in …, 2024 - journals.lww.com
Purpose: The main objective of this work is to know the benefit of a limited etiology strategy
versus an extensive strategy after a first episode of acute non-provoked PE, first on all-cause …

D-Dimer Levels in Patients with Acute Venous Thromboembolism and Occult Cancer: TheDd-Neo Study

B Cosmi, E Lasala, L Borgese, S Cavazza, C Legnani… - 2024 - researchsquare.com
Introduction: Cancer is associated with a prothrombotic state and venous thromboembolism
(VTE) can be the first manifestation of occult cancer. However, no impact on survival of …